Loading
Total declarations
Companies
▲ Purchases (2 ops.)
▼ Sales (1 ops.)
Latest filing published 19 Sept 2011 for GENVEC INC, €3,340.
Insider track record
Disclosed buys
2
Disclosed sells
1
Signal history
No signal scores available.
Closed purchases
Market purchases
2
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Edward M. Connor: trading record in brief
Edward M. Connor discloses dealings in 2 companies, chiefly Medimmune Inc /DE and Genvec Inc. Over a trading history stretching from 15 February 2006 to 19 September 2011, the count stands at 7 filings.
The open-market side counts 2 purchases for €5,218 alongside 1 sale for €1.8M. Sales outweigh purchases by €1.8M. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Outside the open market, there are 2 option exercises. So far in 2011, the count stands at 2 purchases and no sales.
The newest entry dates from 19 September 2011: an open-market purchase of €3,340, in Genvec Inc. The median gap between a trade and its publication by SEC (Form 4) is 4 days. Section 16 rules allow two business days to file each Form 4. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Edward M. Connor
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations7 total
1,600 shares@ US$2.84Common StockSEC:0001140361-11-046325:0
Canonical exit: 18 Dec 2011 (T+90)
900 shares@ US$2.84Common StockSEC:0001140361-11-046325:1
Canonical exit: 18 Dec 2011 (T+90)
10,000 sharesCommon StockSEC:0001179110-07-012175:0
54,000 shares@ US$58.00Common StockSEC:0001179110-07-012175:1
75,000 shares@ US$2.46Common StockSEC:0001104659-07-009758:0
75,000 shares@ US$31.05Common StockSEC:0001104659-07-009758:1
24,000 shares@ US$2.75Common StockSEC:0000873591-06-000013:0
7 of 7 declarations
